norcantharidin has been researched along with Leukocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anjo, A; Blazsek, I; Comisso, M; Legras, S; Liu, XH; Marion, S; Misset, JL; Quittet, P; Wang, GS | 1 |
| Blazsek, I; Breard, J; Comisso, M; Liu, XH; Mathe, G; Misset, JL | 1 |
2 other study(ies) available for norcantharidin and Leukocytosis
| Article | Year |
|---|---|
Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cell Division; Drug Screening Assays, Antitumor; Hematopoietic Stem Cells; Humans; Leukemia; Leukocyte Count; Leukocytes; Leukocytosis; Male; Mice; Mice, Inbred CBA; Mice, Inbred DBA; Tumor Cells, Cultured | 1995 |
Elliptinium, norcantharidin and tetrachlordecaoxide in combined chemo-immunotherapy prolong the survival of Friend-virus-infected mice.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chlorine; Combined Modality Therapy; Drug Synergism; Ellipticines; Friend murine leukemia virus; Immunotherapy; Leukemia, Experimental; Leukocytosis; Male; Mice; Mice, Inbred DBA; Oxides; Splenomegaly; Time Factors | 1991 |